MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$30,664K
Prepaid expenses and
other current assets
$6,167K
Right of use lease
asset
$1,302K
Other non-current
assets
$1,011K
Property and equipment,
net
$544K
Restricted cash
$268K
Total current assets
$36,831K
Total non-current
assets
$3,125K
Total assets
$39,956K
Total liabilities and
stockholders' equity
$39,956K
Total liabilities
$39,045K
Total stockholders'
equity
$911K
Accumulated deficit
-$416,329K
Accumulated other
comprehensive loss
-$7,165K
Total non-current
liabilities
$20,734K
Total current
liabilities
$18,311K
Additional paid-in capital
$424,335K
Common stock, par value
of 0.001 per share...
$70K
Credit Facility
Tranche B
$5,472K
Credit Facility
Tranche A
$4,958K
Term loan debt, net
$16,664K
Common stock warrants
$3,403K
Lease liability -
noncurrent
$667K
Accrued expenses and
other current...
$11,936K
Accounts payable
$5,587K
Lease liability -
current
$788K
Less unamortized
debt issuance costs
$10,430K
Term loan debt
principal
$26,434K
Accrued paid-in-kind
interest
$660K
Back
Back
Balance Sheet
source: myfinsight.com
IO Biotech, Inc. (IOBT)
IO Biotech, Inc. (IOBT)